Table 1.
miRNA/Regulation | Target | Cell source | Observation by using inhibitor/mimic | Reference number |
---|---|---|---|---|
miR-125b ↓ |
SP7 | Human CASMC | Inhibit ALP activity and matrix mineralization | 23 |
miR-141 ↓ |
- | Porcine VIC | Blocks TGF-β-mediated ALP activity | 44 |
miR-223 ↑ |
Mef2c RhoB SMα actin |
Human SMC | Enhance VSMC migration | 32 |
miR-143 miR-145 ↓ |
KLF4 | Human SMC | - | 32 |
miR-30d/e ↓ |
Runx2 | Human SMC | Inhibit ALP activity and matrix mineralization | 42 |
miR-204 ↓ |
Runx2 | Mouse SMC | Inhibit ALP activity and osteocalcin secretion | 28 |
miR-29a/b ↓ |
ADAMTS-7 | Rat SMC | Inhibit matrix mineralization | 52 |
miR-135a*, miR-762, miR-714, or miR-712* ↑ |
NCX PMCA NCKX4 |
Mouse SMC | Promote matrix mineralization | 25 |
Bold; direct binding to 3′UTR not shown in this study, Arrow indicate regulation of miRNA
ALP, alkaline phosphatase; CASMC, coronary artery SMC